Dr. Sotunde predicts the health insurer will shoulder “north of $600 million” in COVID-19-related costs, based on modeling that accounts for a resurgence in COVID-19 cases in recent weeks.
More than half of the costs are related to steps BCBS of North Carolina took to eliminate member cost-sharing for COVID-19 screening, testing and treatment. Other costs included expanded telehealth services, grace periods for premium payments and accelerated claim payments.
Dr. Sotunde said BCBS of North Carolina is in a position to weather the costs, but it’s unclear if they will lead to premium increases next year.
Read more here.
More articles on payers:
UnitedHealth’s earnings double in Q2 as patients deferred elective procedures
BCBS of Massachusetts launches global payment model for primary care clinics
Optum’s revenue grows to $33B in Q2: 5 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
